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We have investigated the nuclear import strategies of high-risk HPV18 L2 minor capsid protein. HPV18 L2 interacts with Kap α2 adapter, and
Kap β2 and Kap β3 nuclear import receptors. Moreover, binding of RanGTP to either Kap β2 or Kap β3 inhibits their interaction with L2,
suggesting that these Kap β/L2 complexes are import competent. Mapping studies show that HPV18 L2 contains two NLSs: in the N-terminus
(nNLS) and in the C-terminus (cNLS), both of which can independently mediate nuclear import. Both nNLS and cNLS form a complex with Kap
α2β1 heterodimer and mediate nuclear import via a classical pathway. The nNLS is also essential for the interaction of HPV18 L2 with Kap β2 and
Kap β3. Interestingly, both nNLS and cNLS interact with the viral DNA and this DNA binding occurs without nucleotide sequence specificity.
Together, the data suggest that HPV18 L2 can interact via its NLSs with several Kaps and the viral DNA and may enter the nucleus via multiple
import pathways mediated by Kap α2β1 heterodimers, Kap β2 and Kap β3.
© 2006 Elsevier Inc. All rights reserved.Keywords: HPV; L2 minor capsid protein; Nuclear import; KaryopherinsIntroduction
About 120 distinct human papillomavirus (HPV) genotypes
have been identified, infecting either the skin or oral/anogenital
mucosal epithelial tissues. Mucosal HPVs have shown varying
degrees of oncogenic potential: high-risk HPV types are
frequently detected in invasive cervical carcinomas and other
anogenital cancers, whereas the low-risk HPV types are
associated with genital warts (benign exophytic condylomas).
HPV16 is the most common type found in cervical cancers
(50%), followed by HPV18 (15%), HPV45 (8%), and HPV31
(5%). The remaining cervical cancers contain other less common
high-risk HPV types (33, 35, 39, 51, 52, 54, 56, 58, 59, 66, 68,
and 69) (zur Hausen, 2000). Although HPV16 is the most
prevalent type in cervical cancers, patients with HPV18-
associated tumors have a relative risk of death several times
greater than that of patients with HPV16-associated carcinomas
(Lombard et al., 1998).Abbreviations: HPV, Human papillomavirus; NLS, Nuclear localization
signal; GST, glutathione S-transferase; Kap, karyopherin.
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doi:10.1016/j.virol.2006.04.007HPV virions (55–60 nm in diameter) consist of a single
molecule of 8 kb double-stranded circular DNA contained
within an icosahedral capsid comprising the L1 major and L2
minor capsid proteins (Doorbar and Gallimore, 1987). The
abundance of the L2 minor capsid protein is about 1/30 that of
L1 (Roden et al., 1996). The L2 protein, which interacts with the
L1 homopentamers (Chen et al., 2000), is essential for the
infectivity of virions, and its roles in the viral infection are
starting to be elucidated. Analysis of the HPV life cycle in raft
cultures has shown that L2 contributes to at least two steps in
the production of infectious virus (Holmgren et al., 2005).
HPV16 L2 minor capsid protein binds to cells (Kawana et al.,
1998; Yang et al., 2003a) and also interacts with β-actin and
these interactions are essential for infection (Yang et al., 2003b).
Recently, it has been shown that L2 contains a membrane-
destabilizing peptide that is required for egress of papilloma-
virus genome from endosomes during the initial phase of
infection (Kamper et al., 2006). Interestingly, BPV1 pseudovir-
ions containing wild-type L1 and derivatives of L2 lacking
either the N-terminal or the C-terminal positively charged
termini are noninfectious despite efficient binding to the cell
surface and endocytosis (Roden et al., 2001). These BPV1 L2
termini can function as NLSs in nuclear import of L2 via a
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site of BPV1 L2 (Fay et al., 2004). Moreover, a BPV1 L2
mutant encoding a scrambled version of the cNLS, which
supports production of virions, rescues the DNA binding but not
the interaction with the karyopherins and nuclear import (Fay et
al., 2004). These data together with the finding that the
incoming L2 and genome colocalize in the nucleus in the initial
stage of infection (Day et al., 2004) would suggest that L2 may
facilitate the nuclear import of the genome after virion
disassembly.
L2 is also imported into the nucleus in the productive stage
of infection when the newly synthesized L2 together with L1
encapsidate the newly replicated viral DNA into virions.
Interestingly, expression and nuclear import of L2 during the
productive stage of the viral cycle precede the expression and
nuclear translocation of L1 in natural lesions (Florin et al.,
2002).
Signal-mediated nuclear import of proteins is performed by
import receptors belonging to the karyopherin β/importin β
(Kap β/Imp β) superfamily that interact with nucleoporins at
the nuclear pore complex to transport the proteins into the
nucleus (Fried and Kutay, 2003; Moroianu, 1999). There are
more than 20 members of the karyopherin β superfamily in
higher eukaryotes transporting a variety of proteins into the
nucleus. Kap β1/importin β, the first one identified, together
with a Kap α/importin α adapter can mediate nuclear import of
proteins that contain basic monopartite or bipartite NLSs via the
classical nuclear import pathway. Kap β1 can also function
without adapters in the import of proteins containing longer
basic NLSs such as ribosomal proteins, core histones, and
several viral proteins, or in conjunction with Imp7, it mediates
nuclear import of histone H1. Mammalian Kap β2/transportin
mediates nuclear import of hnRNP A1 and A2, ribosomal
proteins, and core histones. Interestingly, the ribosomal proteins
and core histones can interact with several nuclear import
receptors (Kap β2/transportin, Kap β3/Imp5, Kap β4, and Imp7)
and enter the nucleus via multiple redundant pathways. Binding
of nuclear Ran-GTP to the Kap βs/importins leads to the
dissociation of the import complexes with the release of theFig. 1. HPV18 L2 has two NLSs in the N-terminus (nNLS) and C-terminus (cNLS
permeabilized HeLa cells were incubated with either GST-nNLS (panels A and E), GS
control (panels D and H) in the presence of either only transport buffer (panels A–Dtransported proteins inside the nucleus (Fried and Kutay, 2003;
Moroianu, 1999).
We have previously determined that the L2 capsid protein of
high-risk HPV16 interacts with several karyopherins and can
enter the nucleus via multiple import pathways (Darshan et al.,
2004). In this study, we investigated the interactions of high-risk
HPV18 L2 minor capsid protein with the karyopherins and with
the viral DNA and mapped and characterized its NLSs and
DNA binding sites.
Results and discussion
HPV18 L2 has two NLSs that can mediate nuclear import via a
classical pathway
Our previous analysis of HPV16 L2 revealed that it contains
two NLSs, localized near the N-terminus and the C-terminus,
which can independently mediate nuclear import of HPV16 L2
(Darshan et al., 2004). These sequences, rich in lysine and
arginine residues, are partially conserved in HPV18 L2. To
determine if these sequences in HPV18 L2 function as NLSs,
we made GST fusion proteins containing the corresponding N-
terminal sequence (nNLS = MVSHRAARRKRA) and the C-
terminal sequence (cNLS = PKKRKRV) of HPV18 L2 and
analyzed them in nuclear import experiments, overlay blot, and
binding assays.
We used nuclear import assays in digitonin-permeabilized
cells to analyze the ability of each of these potential NLSs of
HPV18 L2 to mediate nuclear import of a GST reporter
protein. Digitonin permeabilizes the plasma membrane but
leaves the nuclear envelope intact and, as a consequence,
digitonin-permeabilized HeLa cells retain intact import-
competent nuclei but are largely depleted of cytosolic
transport factors. Digitonin-permeabilized HeLa cells were
incubated with either GST-nNLS, GST-cNLS, GST-NLS16L1,
or GST itself in the presence of either only transport buffer
(Fig. 1, panels A–D) or exogenous cytosol (Fig. 1, panels E–
H). We found that both nNLS and cNLS were able to mediate
nuclear import of the GST reporter protein in the presence of) that can mediate nuclear import in digitonin-permeabilized cells. Digitonin-
T-cNLS (panels B and F), GST-NLS16L1 (panels C and G), or GST, as a negative
) or HeLa cytosol (panels E–H). Note the nuclear import in panels E–G.
Fig. 3. HPV18 L2 minor capsid protein interacts with Kap α2 adapter. Purified
HPV18 L2 was subjected to SDS–PAGE and transferred onto a nitrocellulose
membrane. The L2 blots were incubated with either anti-His Ab (lane 1), anti-L2
Ab (lane 2), or with increasing amounts of Kap α2 adapter and the bound Kap α2
was detected with a specific Ab (lanes 3–5).
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control GST-NLS16L1 (Fig. 1, panel G). As expected, the
GST-negative control was not imported into the nuclei in the
presence of cytosol (Fig. 1, panel H). We also tested in
nuclear import a GST fusion protein containing a middle
sequence (287LTSRRGTVRFSRLGQRATMFTR308) of
HPV18 L2 rich in basic amino acids (called mL218). This
mL218 was unable to mediate nuclear import of the GST
reporter in digitonin-permeabilized cells in the presence of
exogenous cytosol (data not shown). Moreover, in transfec-
tion experiments with EGFP-L2 and EGFP-L2ΔNΔC variant
(lacking both nNLS and cNLS) in GP2-293 cells, the EGFP-
L2ΔNΔC localized in the cytoplasm (Fig. 2, panel E) in
contrast with the wild-type EGFP-L2, which was mostly in
the nucleus (Fig. 2, panel D). We obtained similar results in
transfection experiments with EGFP-L2 and EGFP-L2ΔNΔC
variant in HeLa cells (data not shown). To note, that although
the EGFP is small enough to passively diffuse through the
nuclear pore complex, the EGFP-L2 (as well as L2 itself) is
well above the limit of passive diffusion and its nuclear
localization requires NLS(s). These data suggest that when
both nNLS and cNLS are deleted, the HPV18 L2 protein is
no longer able to enter the nucleus.
As both nNLS and cNLS resemble classical monopartite
type of NLSs, we first tested the interaction of HPV18 L2 and
its NLSs with the Kap α2 adapter using overlay blot assays,
as we described for HPV16 L2 (Darshan et al., 2004).
Incubation of HPV18 L2 blots with increasing concentrations
of Kap α2 resulted in increased binding of Kap α2 to L2 (Fig.
3, lanes 3–5). Overlay blot analysis of the interactions of
HPV18 L2 NLSs with Kap α2 showed that the cNLS
interacted with Kap α2 with high affinity (Fig. 4, lanes 7–10)
and the nNLS with much lower affinity than the cNLS (Fig.
4, compare lanes 2–5 with lanes 7–10). As expected, the
NLS of HPV16 L1, used as a positive control, interacted with
Kap α2 (Fig. 4, lanes 12–15), whereas the GST itself did not
(Fig. 4, lane 17).Fig. 2. In transfected cells, EGFP-L2 localizes to the nucleus, whereas EGFP-L2ΔNΔ
L2 (panels A and D), EGFP-L2ΔNΔC plasmids (panels B and E), or EGFP (panels
Panels A–C represent the DAPI staining of the nuclei and panels D–F represent theIn agreement with these data, the binding assays with the
GST-NLSs immobilized on glutathione–Sepharose beads and
incubated with the Kaps in solution revealed that both nNLS
and cNLS formed a complex with Kap α2β1 heterodimers (Fig.
5, lanes 3 and 6) via interaction with Kap α2 adapter (Fig. 5,
lanes 1 and 4), although the nNLS had a lower affinity (Fig. 5,
compare lanes 1 and 3 with lanes 4 and 6). Neither the nNLS nor
the cNLS interacted directly with Kap β1 (Fig. 5, lanes 2 and 5).
As expected, the NLS16L1, used as a positive control, formed a
complex with Kap α2β1 heterodimers via interaction with Kap
α2 (Fig. 5, lanes 7 and 9), whereas the GST did not (Fig. 5, lanes
10 and 12).
Analysis of nuclear import of the GST-NLSs of HPV18 L2 in
digitonin-permeabilized cells revealed that both nNLS and the
cNLS could mediate nuclear import of a GST reporter protein in
the presence of recombinant Kap α2β1 heterodimers plus
RanGDP, with the cNLS being more efficient than the nNLSC localizes to the cytoplasm. GP2-293 cells were transfected with either EGFP-
C and F) and examined by fluorescence microscopy at 24 h post-transfection.
fluorescence of the EGFP.
Fig. 4. The nNLS and cNLS of HPV18 L2 interact with Kap α2 adapter with different affinities. Blots containing GST-nNLS18L2 (lanes 2–5), GST-cNLS18L2 (lanes 7–
10), or GST-NLS16L1, as a positive control (lanes 12–15), or GST, as a negative control (lane 17), were incubated with increasing amounts of Kap α2 and the bound
Kap α2 was detected with an anti-Kap α2 antibody. The different GST-NLS proteins and the GST were detected with an anti-GST antibody (lanes 1, 6, 11, and 16
respectively).
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a positive control for the classical pathways, was also imported
in the presence of Kap α2β1 heterodimers plus RanGDP (Fig. 6,
panel G), whereas the GST-negative control was not (Fig. 6,
panel H).
Together, the data indicate that HPV18 L2 has two NLSs,
one at the N-terminus and another at the C-terminus, which can
form complexes with Kap α2β1 heterodimers and independent-
ly mediate nuclear import via a classical pathway. Although
HPV16 L2 also has two NLSs interacting with Kap α2β1
heterodimers, there are differences in the binding affinities of
the two NLSs of HPV16 L2 versus HPV18 L2: the cNLS of
HPV18 L2 has a higher affinity than the nNLS, whereas the
opposite is true for HPV16 L2 (Darshan et al., 2004). The
biological significance of this difference between the NLSs of
HPV16 L2 and HPV18 L2, if any, remains to be established.Fig. 5. Both nNLS and cNLS of HPV18 L2 form a complex with Kap α2β1 heterodim
(lanes 7–9), and GST (lanes 10–12) immobilized on glutathione–Sepharose (2 μg/10
2, 5, 8, and 11), or Kap β1 + Kap α2 (lanes 3, 6, 9, and 12). Bound proteins were elute
The input of Kap α2 and Kap β1 is shown in lanes 13 and 14.HPV18 L2 interacts directly with Kap β2 and Kap β3 nuclear
import receptors and deletion of its nNLS inhibits these
interactions
We next analyzed if HPV18 L2 can interact directly with
Kap β nuclear import receptors. The L2 blots were incubated
with increasing concentrations of either GST-Kap β2 (Fig.
7A, lanes 3–6) or GST-Kap β3 (Fig. 8A, lanes 3–5), and the
bound GST-Kaps were detected with an anti-GST antibody.
We determined that GST-Kap β2 bound to L2 at concentra-
tions of 5 and 10 μg/ml (Fig. 7A, lanes 5 and 6) but not at
concentrations of 1 and 2.5 μg/ml (Fig. 7A, lanes 3 and 4).
The GST alone did not interact with HPV18 L2 (Fig. 7A, lane
2). Significantly, Ran-GTP inhibited the interactions between
GST-Kap β2 and L2 (Fig. 7B, compare lanes 1 and 2),
suggesting that the complex between L2 and Kap β2 can beers. GST-nNLS18L2 (lanes 1–3), GST-cNLS18L2 (lanes 4–6), GST-NLSHPV16L1
μl beads) were incubated with either Kap α2 (lanes 1, 4, 7, and 10), Kap β1 (lanes
d with sample buffer and analyzed by SDS–PAGE and Coomassie blue staining.
Fig. 6. Both nNLS and cNLS can mediate nuclear import via a classical pathway. Digitonin-permeabilized HeLa cells were incubated with either GST-nNLS (panels A
and E), GST-cNLS (panels B and F), GST-NLS16L1 (panels C and G), or GST as a negative control (panels D and H) in the presence of either only transport buffer
(panels A–D) or Kap α2β1 heterodimers plus RanGDP (panels E–H). Note the nuclear import in panels E–G.
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nucleus. Interestingly, we also found that L2 binds with high
affinity to the Kap β3 receptor (Fig. 8A, lanes 4 and 5) and
Ran-GTP inhibited the interaction between GST-Kap β3 and
L2 (Fig. 8B, compare lanes 1 and 2). The GST-negative
control did not bind to the L2 protein (Fig. 8A, lane 3). The
high affinity binding of HPV18 L2 to Kap β3 would suggest
that the Kap β3-mediated nuclear import pathway may be
preferentially used by L2 in conditions of competition with
host proteins for the classical pathway.
To determine the binding domain(s) of HPV18 L2 for
Kap β2 and Kap β3 import receptors, we performed
binding assays with the wild-type L2 and the corresponding
L2 variants (L2ΔN lacking the nNLS, L2ΔC lacking the
cNLS, and L2ΔNΔC lacking both NLSs). GST-Kap β2 and
GST-Kap β3 immobilized on glutathione–Sepharose beads
were incubated with either wild-type L2 or the L2 mutants
(Fig. 9). The wild-type L2 and the L2ΔC mutant bound to
both Kap β2 and Kap β3 (Fig. 9, lanes 2, 4, 7, and 9),
whereas the L2ΔN and L2ΔNΔC mutants did not (Fig. 9,
lanes 3, 5, 8, and 10). The wild-type L2 did not interactFig. 7. HPV18 L2 interacts with Kap β2 nuclear import receptor and RanGTP
inhibits this interaction. (A) HPV18 L2 blots were incubated with either anti-L2
Ab (lane 1), or with 5 μg/ml GST (lane 2), or with increasing amounts of GST-
Kap β2 (lanes 3–6). Bound GST-Kap β2 and GST were detected with an anti-
GST Ab. (B) HPV18 L2 blots were incubated with GST-Kap β2 in the absence
(lane 1) or presence of RanGTP (lane 2).with the GST itself (Fig. 9, lane 12). These data indicate
that the nNLS of HPV18 L2 is essential for the interaction
with both Kap β2 and Kap β3 receptors. However, in
binding assays the GST-nNLS immobilized on glutathione–
Sepharose beads did not interact with either Kap β2 or Kap
β3 (data not shown). This suggests that although the nNLS
is required for the interaction with Kap β2/3 it is not
sufficient, and the binding sites may contain additional
amino acids.
Previously, we have shown that the high-risk HPV16 L2
interacts with Kap α2β1 heterodimers and Kap β2 and Kap
β3 import receptors (Darshan et al., 2004). Thus, HPV18
L2 has a similar pattern of interactions as HPV16 L2.
Although the BPV1 L2 protein interacts with Kap α2β1
heterodimers, it does not interact with either Kap β2 or Kap
β3 receptors (Fay et al., 2004). These data show that the
HPV L2 capsid proteins evolved multiple interactions with
the host nuclear import receptors in comparison with the
bovine papillomavirus L2 protein, and consequently they
are able to enter the nucleus of host cells via different
import pathways.Fig. 8. HPV18 L2 interacts with Kap β3 nuclear import receptor and RanGTP
inhibits this interaction. (A) HPV18 L2 blots were incubated with either anti-L2
Ab (lane 1) or with 5 μg/ml GST (lane 2) or with increasing amounts of GST-
Kap β3 (lanes 3–6). Bound GST-Kap β3 and GST were detected with an anti-
GST Ab. (B) HPV18 L2 blots were incubated with GST-Kap β3 in the absence
(lane 1) or presence of RanGTP (lane 2).
Fig. 9. Deletion of the nNLS of HPV18 L2 inhibits its interaction with Kap β2
and Kap β3 receptors. GST-Kap β2 immobilized on glutathione–Sepharose
beads (lane 1) was incubated with either wild-type L2 (lane 2), L2ΔN (lane 3),
L2ΔC (lane 4), or L2ΔNΔC (lane 5). GST-Kap β3 immobilized on glutathione–
Sepharose beads (lane 6) was incubated with either wild-type L2 (lane 7), L2ΔN
(lane 8), L2ΔC (lane 9), or L2ΔNΔC (lane 10). GST immobilized on
glutathione–Sepharose beads (lane 11) was incubated with wild-type L2 (lane
12). The input of wild-type L2 (lane 13), L2ΔN (lane 14), L2ΔC (lane 15), and
L2ΔNΔC (lane 16).
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the viral DNA
Previous results with BPV1 L2 revealed that it interacts with
the DNA in a sequence-independent manner and that its cNLS is
the major DNA binding site (Fay et al., 2004). Here we analyzed
the interactions of the nNLS and cNLS of HPV18 L2 and
HPV16 L2 with the HPV16 DNA plasmid using DNA mobility
shift assays as described (Fay et al., 2004). We found for both
HPV18 L2 and HPV16 L2 that both nNLS and cNLS interacted
efficiently with the DNA, with the NLSs of HPV16 L2 having a
higher affinity than the NLSs of HPV18 L2 (Fig. 10A). To
investigate if the interactions are DNA sequence specific, we
also incubated an unrelated DNA ladder with the GST-NLSs of
HPV18 L2 and HPV16 L2. Both nNLS and cNLS of HPV18 L2
and HPV16 L2 interacted with the unrelated DNA demonstrat-
ing that the interactions are independent of the DNA sequenceFig. 10. The nNLS and cNLS of high-risk HPV18 L2 and HPV16 L2 are the maj
increasing amounts (1, 2, or 5 μg of protein) of either GST-nNLS16L2 (lanes 2–4), GST
13), or 10 μg of GST (lane 14) and analyzed via agarose gel electrophoresis. (B) HPV
2–4), GST-mL218 (lanes 5–7), 1 and 2 μg of GST-NLS16L1, as a positive control (la
incubated with 0.5 and 1 μg of wild-type HPV18 L2 (lanes 2 and 3), 0.5, 1, and 2(data not shown). We also tested for DNA interactions the
Arg/Lys-rich sequences located in the middle of HPV18 L2
(mL218: 287LTSRRGTVRFSRLGQRATMFTR308) and
HPV16 L2 (mL216: 296SRRTGIRYSRIGNKQTLRTRSGK318).
The basic residues of these sequences are mostly conserved in
HPV L2 proteins, but they are not in the BPV1 L2 protein. DNA
mobility shift assays showed that both mL218 and mL216
interact with the DNA (Fig. 10B, lanes 2–7). However,
comparison of the interactions of wild-type HPV18 L2 and
the L2ΔNΔC double mutant with the DNA revealed that
deletion of both NLSs of HPV18 L2 strongly inhibits its
interaction with the DNA (Fig. 10C, compare lanes 2 and 3 with
lanes 4, 5, and 6). Similar results were obtained for HPV16 L2
(data not shown). These data suggest that the major DNA
binding sites for the L2 minor capsid proteins of HPV18/16 are
the nNLS and cNLS. However, we cannot exclude the
possibility that the Arg/Lys mL2 sequence may contribute to
the interaction of L2 with the DNA during the viral cycle. For
BPV1 L2, we have previously found that only the cNLS
interacts efficiently with the DNA (Fay et al., 2004). Moreover,
a BPV1 L2 mutant encoding a scrambled version of the cNLS,
which rescues the production of infectious virions (Roden et al.,
2001), rescued the DNA binding but not the interaction with the
karyopherins and nuclear import, suggesting that the role of the
BPV1 L2 cNLS in infectivity may be its interaction with the
viral DNA (Fay et al., 2004). For HPV18 and HPV16 L2 capsid
proteins, both nNLS and cNLS can interact with the DNA,
suggesting that HPV L2 proteins have the potential to facilitate
nuclear import of the viral DNA in the initial phase of infection
after virion disassembly. Future studies will determine if HPV
L2 proteins can simultaneously interact with both the viral DNA
and the karyopherins and mediate nuclear import of the DNA.
Overall our data in this study suggest that the L2 minor
capsid protein of high-risk HPV18 can interact via its two NLSs
with several karyopherins and the viral DNA and may enter the
nucleus via multiple import pathways mediated by Kap α2β1
heterodimers, Kap β2, and Kap β3.or DNA binding sites. (A) HPV16 DNA plasmid (lane 1) was incubated with
-nNLS18L2 (lanes 5–7), GST-cNLS16L2 (lanes 8–10), GST-cNLS18L2 (lanes 11–
16 DNA plasmid was incubated with 1, 2, and 5 μg of either GST-mL216 (lanes
nes 8 and 9), or 5 μg of GST (lane 10). (C) HPV16 DNA plasmid (lane 1) was
μg of L2ΔNΔC double mutant (lanes 4–6), or 5 μg of GST (lane 7).
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Preparation of recombinant human nuclear import factors
His-tagged Kap α2/hSRP1α (Weis et al., 1995) and His-
tagged Kap β1/p97 (Chi et al., 1996) were expressed in
Escherichia coli BL21 Star and E. coli BL21(DE3), respec-
tively (3 h induction with 2 mM IPTG at 30 °C), and the soluble
His-tagged proteins were purified in their native state on Talon
beads using a standard procedure. GST-Kap β1 (Chi et al.,
1996), GST-Kap β2 (Chook and Blobel, 1999) were expressed
in E. coli BL21(DE3), and GST-Kap β3 (Yaseen and Blobel,
1997) was expressed in E. coli BL21-CodonPlus (3 h induction
with 1 mM IPTG at 30 °C), and the soluble GST-Kap β fusion
proteins were purified in their native state on glutathione–
Sepharose beads using a standard procedure. Human Ran
(Coutavas et al., 1993) was prepared as described (Floer and
Blobel, 1996). Ran was loaded with GTP by incubation with
100 mM GTP, 0.5 M EDTA, 1 M DTT, and 1 M HEPES (pH
7.4) for 30 min at RT and the reaction was stopped with 1.5 M
magnesium chloride (pH 7.4). All proteins were checked for
purity and lack of proteolytic degradation by SDS–PAGE and
Coomassie blue staining. The purified proteins were dialyzed in
transport buffer (20 mM HEPES-KOH, pH 7.3, 110 mM
potassium acetate, 2 mM magnesium acetate, 1 mM EGTA,
2 mM DTT, plus protease inhibitors) and stored in aliquots
at −80 °C until use. HeLa cytosol from the National Cell
Culture Center (Minneapolis, MN) was centrifuged and stored
in small aliquots at −80 °C.
Preparation of HPV18 L2 protein and L2 mutants
The pProEX HTb plasmid vector containing the HPV18 L2
wild type (Roden et al., 1994) was a kind gift from Dr. Richard
Roden. To prepare the L2 deletion mutants (L2ΔN lacking aa
1–12, L2ΔC lacking aa 445–451, and the L2ΔNΔC double
mutant), we used the QuikChange Site-Directed Mutagenesis
Kit from Stratagene. The constructs were transformed into XL1
blue bacteria and confirmed by automated sequence analysis
(MGH DNA Sequencing Department). The His-tagged HPV18
L2 wild-type (Roden et al., 1994) and the corresponding L2
mutants were expressed in E. coli BL21-CodonPlus (2 h in-
duction with 2 mM IPTG at 25 °) and purified from inclusion
bodies using the Novagen Protein Refolding kit as previously
described (Darshan et al., 2004). For binding assays and DNA
mobility shift assays, the L2 and L2 mutants were purified in
urea on Talon beads as recommended (Qiagen Inc.), followed
by extensive dialysis in transport buffer to allow refolding of
the proteins.
Preparation of GST-NLS fusion proteins
The N-terminal sequence (1MVSHRAARRKRA12), the
middle sequence (287LTSRRGTVRFSRLGQRATMFTR308),
and the C-terminal sequence (445PKKRKRV451) of HPV18 L2
were separately fused to a GST reporter to obtain the GST-
nNLS, GST-mL218, and GST-cNLS. To make the GST-NLSconstructs, the corresponding forward and reverse oligonucleo-
tides containing an EcoRI and XhoI restriction-cutting sites were
annealed and inserted directly into the pGEX4T-1 vector, which
had been double cut with the same enzymes. The GST-NLS
constructs were transformed in XL1 blue bacteria and confirmed
by automated sequence analysis (MGH DNA sequencing
department). For protein expression, the GST-nNLS, GST-
mL218, and GST-cNLS constructs were used to transform E. coli
BL21 CodonPlus. After induction of the bacteria with 1 mM
IPTG for 2 h at 28°, the GST fusion proteins were purified in
their native state on glutathione–Sepharose using a standard
procedure. The GST-NLSHPV16L1 containing the monopartite
NLS (AKRKKRKL) of HPV16 L1 major capsid protein was
prepared as previously described (Nelson et al., 2002).
Preparation of GFP fusion proteins for transfection assays
The EGFP expression plasmid pEGFP-C1 (Clontech, Inc.)
was used to construct the EGFP fusion protein expression
plasmids (EGFP-L2, and EGFP-L2ΔNΔC lacking both nNLS
and cNLS). The pEGFP-C1 plasmid was double digested with
EcoRI and BamHI, run on a 0.7% agarose gel, and extracted by
the protocol from the QIAquick Gel Extraction Kit (Qiagen).
DNA fragments spanning the HPV18 L2 or the L2 mutant
plasmids were amplified using PCR oligonucleotides that added
an EcoRI and BamHI restriction endonuclease sites and the
DNA fragments were ligated into the EcoR1 and BamHI
cloning sites on pEGFP-C1. The resulting plasmids were
transformed into XL1-Blue cells, and the purified plasmids
were confirmed by sequence analysis.
Antibodies
An Ab to HPV16 L2 that recognizes HPV18 L2 was
obtained as described (Roden et al., 2000). A mouse antibody to
Kap α2/Rch1 was from Transduction Laboratories; a mouse
antibody to 6× His tag and a goat anti-GST antibody were from
Amersham Biosciences. HRP-conjugated secondary antibodies
(anti-rabbit, anti-mouse, and anti-goat) were from Santa Cruz
Biotechnology.
Overlay blot assays
For analysis of the interactions of HPV18 L2 with the
karyopherins, we used overlay blot assays as previously
described for HPV16 L2 (Darshan et al., 2004). Briefly, the
wild-type L2 and the L2 mutants, different GST-NLS fusion
proteins, or GST (all the proteins at 2 μg/lane), were subjected
to SDS–PAGE and transferred to nitrocellulose membrane.
After blocking, the individual blots were incubated with
different Kaps and the bound Kaps detected with specific Abs
as indicated in the figure legends.
In solution binding assays
Binding assays were performed as previously described
(Nelson et al., 2002). Briefly, the different GST-NLSs, or GST
207K. Klucevsek et al. / Virology 352 (2006) 200–208itself, immobilized on glutathione–Sepharose beads (2 μg/10 μl
beads) were incubated under rotation for 1 h at RT with the
purified Kaps in binding buffer (transport buffer containing
0.01% Tween 20) as indicated in the figure legends. We also
carried out binding assays with GST-Kap β2 and GST-Kap β3
immobilized on glutathione–Sepharose beads (2 μg/10 μl
beads) incubated with wild-type L2 and the different L2 mutants
(L2ΔN, L2ΔC, and L2ΔNΔC). The bound proteins were
eluted with SDS–PAGE sample buffer and analyzed by SDS–
PAGE and Coomassie Blue staining.
In vitro nuclear import assays
The nuclear import assays were carried out as previously
described (Nelson et al., 2002). Briefly, subconfluent HeLa
cells, grown on poly-L-lysine-coated glass coverslips for 24 h,
were permeabilized with 70 μg/ml digitonin for 5 min on ice
and washed with transport buffer. All import reactions
contained an energy regenerating system (1 mM GTP, 1 mM
ATP, 5 mM phosphocreatine, and 0.4 U creatine phosphoki-
nase), plus either HeLa cytosol or various transport factors (1 μg
Kap α2; 0.5 μg Kap β1; 3 μg RanGDP), plus the different
GST-NLS fusion proteins (0.5 μg). Final import reaction
volume was adjusted to 20 μl with transport buffer. For
visualization of nuclear import, the GST-NLS fusion proteins
were detected by immunofluorescence with an anti-GST
antibody, as previously described (Nelson et al., 2002). The
nuclei were identified by DAPI staining. Nuclear import was
analyzed with a Nikon Eclipse TE 300 Microscope that has a
fluorescence attachment and a Sony DKC-5000 CCD
camera.
Transfection experiments
GP2-293 cells (BD Biosciences Clontech, CA) were plated
on 12 mm poly-L-lysine-coated glass coverslips to 50–70%
confluency 24 h prior to transfection. Cells in each well were
transfected with 0.8 μg plasmid and 3 μl FUGENE 6 (Roche
Applied Science, IN) in 500 μl DMEM prepared following
product protocol. Media were changed to DMEM with
10% FBS and pen-strep after 6 h and the cells were fixed
24 h after the initial transfection with 10% formaldehyde in
PBS (10 min). Coverslips were mounted using Vectashield-
Dapi (Vecor Labs, CA) mounting medium and examined by
fluorescence microscopy using a Nikon Eclipse TE 300
Microscope.
DNA mobility shift assays
DNA mobility shift assays were performed as previously
described (Fay et al., 2004). Briefly, the proteins to be tested
for DNA binding were incubated with either HPV16 DNA
plasmid or an unrelated DNA for 30 min at RT in transport
buffer. GST-NLSHPV16L1 was used as a positive control and
GST as a negative control. The DNA or DNA–protein
complexes were analyzed by electrophoresis in 0.7% agarose
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